triiodothyronine has been researched along with Angina Pectoris in 18 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adrenergic responsiveness after abrupt propranolol withdrawas during exogenous and esdogenous catecholamine stimulation was assessed in 10 normal subjects and 10 patients with angina pectoris." | 7.66 | Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. ( Crawford, MH; Horwitz, LD; Levine, SP; Lindenfeld, J; Montiel, MM; O'Rourke, RA, 1980) |
| "Therapeutic use of the potent antiarrhythmic drug amiodarone requires early detection of impending hyperthyroidism, a potentially life-threatening adverse reaction in cardiac patients." | 3.67 | Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis. ( Stäubli, M; Studer, H, 1985) |
| " All were taking large daily doses of propranolol--480 +/- 155 (+/- SE) mg--for treatment of angina pectoris." | 3.66 | Hyperthyroxinemia in patients treated with high-dose propranolol. ( Cooper, DS; Daniels, GH; Ladenson, PW; Ridgway, EC, 1982) |
| "Adrenergic responsiveness after abrupt propranolol withdrawas during exogenous and esdogenous catecholamine stimulation was assessed in 10 normal subjects and 10 patients with angina pectoris." | 3.66 | Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. ( Crawford, MH; Horwitz, LD; Levine, SP; Lindenfeld, J; Montiel, MM; O'Rourke, RA, 1980) |
| "The triiodothyronine level was lower on the 2nd day of the disease, the thyroxine content decreased on the 10th day of the disease but became normal on the 20-25th day." | 1.26 | [Thyroid hormones, cholesterol, erythrocyte aggregation and fibrinogen degradation products in acute myocardial infarct]. ( Kellner, K; Liusov, VA; Marek, H; Rudakov, AV; Titlbach, O, 1980) |
| " In spite of the high iodine content, amiodarone does not, therefore, depress thyroid function to any important degree during chronic administration and its antianginal action does not appear to be caused by the production of generalized hypothyroidism." | 1.25 | Effects of amiodarone on thyroid function in patients with ischaemic heart disease. ( Hurley, PJ; Pritchard, DA; Singh, BN, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (77.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brozaitiene, J | 1 |
| Mickuviene, N | 1 |
| Podlipskyte, A | 1 |
| Burkauskas, J | 1 |
| Bunevicius, R | 1 |
| LERMAN, J | 1 |
| Evrengul, H | 1 |
| Tanriverdi, H | 1 |
| Enli, Y | 1 |
| Kuru, O | 1 |
| Seleci, D | 1 |
| Bastemir, M | 1 |
| Kilic, A | 1 |
| Kaftan, A | 1 |
| Kilic, M | 1 |
| Singh, BN | 2 |
| Pimenov, LT | 1 |
| Leshchinskiĭ, LA | 1 |
| Cooper, DS | 1 |
| Daniels, GH | 1 |
| Ladenson, PW | 1 |
| Ridgway, EC | 1 |
| Marek, H | 1 |
| Titlbach, O | 1 |
| Kellner, K | 1 |
| Liusov, VA | 1 |
| Rudakov, AV | 1 |
| Lindenfeld, J | 1 |
| Crawford, MH | 1 |
| O'Rourke, RA | 1 |
| Levine, SP | 1 |
| Montiel, MM | 1 |
| Horwitz, LD | 1 |
| Peters, A | 1 |
| Ehlers, M | 1 |
| Blank, B | 1 |
| Exler, D | 1 |
| Falk, C | 1 |
| Kohlmann, T | 1 |
| Fruehwald-Schultes, B | 1 |
| Wellhoener, P | 1 |
| Kerner, W | 1 |
| Fehm, HL | 1 |
| Friberg, L | 1 |
| Werner, S | 1 |
| Eggertsen, G | 1 |
| Ahnve, S | 1 |
| Kuch, J | 1 |
| Ceremuzyński, L | 1 |
| Lada, W | 1 |
| Pritchard, DA | 1 |
| Hurley, PJ | 1 |
| Gel'shteĭn, GG | 1 |
| Fitilev, SB | 1 |
| Saprygin, DB | 1 |
| Migalina, LA | 1 |
| Besshapov, EP | 1 |
| Gitlin, MJ | 1 |
| Stäubli, M | 1 |
| Studer, H | 1 |
| Steinberg, AD | 1 |
| Schrader, ZR | 1 |
| Phipps, FC | 1 |
| Stokinger, HE | 1 |
| Conte, N | 1 |
| Macrì, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Endocrine Changes in Adults Undergoing Cardiac Surgery[NCT03736499] | 500 participants (Anticipated) | Observational | 2018-07-01 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for triiodothyronine and Angina Pectoris
| Article | Year |
|---|---|
Amiodarone: historical development and pharmacologic profile.
Topics: Action Potentials; Amiodarone; Angina Pectoris; Animals; Arrhythmias, Cardiac; Benzofurans; Electrop | 1983 |
17 other studies available for triiodothyronine and Angina Pectoris
| Article | Year |
|---|---|
Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; C-Reactive Protein; Coronary Artery Disease; Female; | 2016 |
TREATMENT OF HYPOTHYROIDISM.
Topics: Adrenocorticotropic Hormone; Angina Pectoris; Coma; Cortisone; Diagnosis; Goiter; Humans; Hypothyroi | 1964 |
Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.
Topics: Aged; Angina Pectoris; Blood Flow Velocity; Case-Control Studies; Coronary Angiography; Coronary Cir | 2007 |
[Thyroid hormone changes (iodothyroninemia) in patients with acute myocardial infarction, and their clinical significance].
Topics: Adult; Angina Pectoris; Cardiomyopathy, Dilated; Humans; Middle Aged; Myocardial Infarction; Prognos | 1984 |
Hyperthyroxinemia in patients treated with high-dose propranolol.
Topics: Aged; Angina Pectoris; Female; Humans; Male; Middle Aged; Propranolol; Thyrotropin-Releasing Hormone | 1982 |
[Thyroid hormones, cholesterol, erythrocyte aggregation and fibrinogen degradation products in acute myocardial infarct].
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Coronary Disease; Erythrocyte Aggregation; Fibrin Fibrino | 1980 |
Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Catecholamines; Dopamine beta-Hydroxylase; Echocardiog | 1980 |
Excess triiodothyronine as a risk factor of coronary events.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cross-Sectional Studies; Female; Humans; Logistic M | 2000 |
Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina?
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Biomarkers; Case-Control Studies; Down-Regulation; | 2002 |
Thyroid activity coefficients in intractable angina pectoris.
Topics: Adult; Angina Pectoris; Animals; Humans; Male; Middle Aged; Thyroid Function Tests; Thyroid Gland; T | 1975 |
Effects of amiodarone on thyroid function in patients with ischaemic heart disease.
Topics: Amiodarone; Angina Pectoris; Benzofurans; Blood Pressure; Cholesterol; Coronary Disease; Heart Rate; | 1975 |
[Thyroid hormone content of the blood plasma and tolerance for physical loading in ischemic heart disease patients].
Topics: Angina Pectoris; Coronary Circulation; Coronary Disease; Humans; Male; Middle Aged; Physical Enduran | 1987 |
L-triiodothyronine-precipitated angina and clinical response.
Topics: Angina Pectoris; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Huma | 1986 |
Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Female; Hum | 1985 |
Myxoedema with angina pectoris treated with propranolol and triiodothyronine.
Topics: Age Factors; Angina Pectoris; Humans; Male; Middle Aged; Myxedema; Pericardial Effusion; Propranolol | 1971 |
The influence of the thyroid on the acute toxicity of a dynamite-sensitizing mixture.
Topics: Angina Pectoris; Animals; Epinephrine; Glycols; Hyperthyroidism; Hypothyroidism; Lethal Dose 50; Mal | 1972 |
[Electrocardiographic observations in the first phase of opotherapy of hypothyroidism].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Hypertensio | 1967 |